In this cohort at @ months , those given prasugrel experienced significantly fewer ischemic events ( cardiovascular death , non-fatal myocardial infarction , or non-fatal stroke , @ % vs @ % , hazard ratio ( HR ) = @ , p < @ , than those given clopidogrel , with a non-significant increase in non-coronary artery bypass graft ( CABG ) TIMI major bleeding , @ % vs @ % , HR = @ , p = @ ; similarly , in the overall cohort these frequencies were @ % vs @ % , HR = @ , p < @ , for cardiovascular death , non-fatal myocardial infarction , or non-fatal stroke , and @ % vs @ % , HR = @ , p = @ , for non-CABG TIMI major bleeding .